Market Analysis - Monthly Report - November, 2020 - Oseltamivir phosphate

In the alternate seasons of winter and spring, there was no major flu outbreak. It is because the outbreak of the new crown pneumonia epidemic in 2020 has caused a sudden change in the market environment. Home isolation has blocked the spread of the new crown virus and also reduced the cases of influenza virus infection, and the market demand for OSELTAMIVIR has declined. Although the new crown epidemic has concealed the trend of influenza, with the epidemic under control in most countries around the world and the restoration of daily order, oseltamivir as a classic treatment and reserve medicine for influenza still has a huge market demand.

The huge market demand has ignited the enthusiasm of many generic drug companies to develop this product. In the domestic market, many companies have successively submitted applications for the listing of generic drugs for oseltamivir. Market competition has directly led to the decline of raw material market prices. At the same time, with the increase in the production process of Shikimic acid, the raw material of oseltamivir, the production cost is reduced, and the price of the raw material is indirectly reduced. The price of oseltamivir has been falling all the way, and it is still trending towards price reduction.Future prices remain to be seen.

As for the future market competition pattern of oseltamivir, it will take the Lead in the Asia-Pacific region. Although the market is currently dominated by North America, experts predict that it will be replaced by the Asia-Pacific market by the end of 2027. The Tamiflu drug market in North America has been growing positively due to the high prevalence of influenza and the increase in FDA approved drugs. Due to major market players, Europe is considered to be the second largest growing regional market, and there is an increasing focus on mental health. Due to the development of healthcare facilities, a large number of generic drug manufacturers, as well as government programs and expert groups, the Asia-Pacific region is expected to lead the market.